Personalized Anesthesia and Perioperative Coagulation Management: a Main Step Forward by Dabbagh, Ali






Personalized Anesthesia and Perioperative Coagulation 




Perioperative bleeding management is one of the 
greatest challenges for anesthesiologists. Not too many 
years ago, there were a few available options for 
anesthesiologists on table; both regarding diagnosis 
and replacement therapies. However, time has changed 
and many up-to-date approaches have been introduced 
during the last decades. 
During the perioperative period, the most 
common etiology for nonsurgical bleeding is 
underlying coagulation disorder which could be due to 
the effects of the procedure or due to an underlying 
disorder which often undiagnosed or insufficiently 
assessed. However, as all of the underlying disorders 
are not always well-known and some of them remain 
undetected, there is always room for further clinical 
developments and research work. Besides, a unique 
strategy for all patients to optimize the coagulation 
profile would not be always suitable; different suits 
should be tailored for each person. This is why 
choosing a personalized approach in perioperative 
hematologic optimization and coagulation 
management remains a logical, suitable and 
recommended approach. 
The strategic move towards component 
therapy and patient blood management has 
significantly improved the clinical outcome (1, 2). 
However, this clinical paradigm shift 
mandated coordinated movement in all aspects and 
could not be achieved without equivalent improvement 
in coagulation status monitoring; especially with the 
help of such monitoring devices as Rotational 
thromboelastometry (ROTEM) and 
thromboelastography (TEG) which could provide 
point of care coagulation status data though more 
sophisticated research is needed to define the ultimate 
role of these monitors on patient outcome (3-7). 
With the overwhelming trend of personalized 
medicine and its role on perioperative care, coagulation 
management would be one of the highly privileged 
aspects with potential improvements in clinical 
outcome (8, 9). Both rare and common congenital 
bleeding disorders could significantly affect the 
perioperative care and the role of point of care tests is 
much more highlighted in these patients.  
In this issue of the Journal, Dorgalaleh et al, 
have presented a study considering prevalence of rare 
and common bleeding disorders in Kurdistan Province 
of Iran with important results probably arising from 
ethnic or geographic effects (10). Both ethnic and 
geographic effects would be among the potential 
derminants of clinical practice. Studies like the latter 
one stress more on point of care testing for coagulation 
management and perioperative patient blood 
management which is best matched as a branch of 
personalized medicine.  
Today, perioperative medicine is improved due 
to personalized medicine; perioperative coagulation 
management is one of the prominent examples of this 
paradigm shift; a continuous trend that would be well 
extended and obeyed with broader aspects during the 
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